Mechanistic Insights into Light-Driven Allosteric Control of GPCR Biological Activity

Area of Science:

• Pharmacology
• Neuroscience
• Biochemistry

Background:

• G protein-coupled receptors (GPCRs), including the metabotropic glutamate 5 receptor (mGlu₅), are key therapeutic targets.
• Allosteric ligands offer precise modulation of GPCR activity, but traditional methods lack spatiotemporal control.
• Photopharmacology utilizes photoswitchable ligands for light-controlled, reversible modulation of receptor activity.

Purpose of the Study:

• To investigate the molecular mechanisms of photoswitchable negative allosteric modulators (NAMs) targeting the mGlu₅ receptor.
• To understand how *trans-cis* azobenzene photoisomerization affects ligand pharmacology and binding.
• To evaluate the potential of these photoswitchable NAMs for precise pain control.

Main Methods:

• Utilized photochemical, cell-based, and *in vivo* photopharmacological approaches.
• Studied two freely diffusible mGlu₅ phenylazopyridine photoswitchable NAMs: alloswitch-1 and MCS0331.
• Analyzed the impact of photoisomerization on ligand affinity and functional activity at the mGlu₅ allosteric pocket.

Main Results:

• Photoisomerization of the azobenzene moiety can occur both inside and outside the mGlu₅ binding pocket.
• Light-induced *cis* isomerization leads to a reversible loss of ligand affinity, partly due to altered dissociation rates.
• Ligand activity shifts from high-affinity NAM to reduced affinity upon *trans* to *cis* photoisomerization.

Conclusions:

• The study elucidates the mechanism of action for photoswitchable mGlu₅ NAMs, demonstrating light-controlled affinity modulation.
• This mechanism enables dynamic and reversible control over pain signaling through targeted photopharmacology.
• Photoswitchable ligands represent a promising strategy for precise therapeutic interventions in pain management.